Targeting LRRK2 mutations in Parkinson’s disease

Targeting LRRK2 mutations in Parkinson’s disease
Future Med Chem. 2022 Jun 22. doi: 10.4155/fmc-2022-0102. Online ahead of print.NO ABSTRACTPMID:35730403 | DOI:10.4155/fmc-2022-0102 ... read more
Source: PubMedPublished on 2022-06-22By Robert K Leśniak